Market News
Stay updated with the latest market trends, earnings, and economic indicators.
IHH hospitals in India, Singapore saw fewer patients from Middle East due to war
IHH Healthcare hospitals in India saw fewer patients from the UAE and Saudi Arabia. Singapore hospitals also faced impacts from the ongoing Middle East conflict. This regional instability creates significant uncertainty for businesses globally. Soaring energy prices and disrupted supply chains are major concerns. IHH previously stated its diversified footprint mitigated earlier geopolitical impacts.
Fortis Healthcare board okays extending MD & CEO Ashutosh Raghuvanshi's tenure by 2 years
Fortis Healthcare's board has approved Ashutosh Raghuvanshi's reappointment as Managing Director. His new term will commence on March 19, 2027, for a period of two years. This reappointment follows the conclusion of his current tenure on March 18, 2027. The board cited his expertise and role in the company's growth for this decision.
Blue Jet Healthcare Announces QIP Launch | RITES Receives Major Overseas Project | Top Buzzing Stocks Today - Equitymaster
Blue Jet Healthcare Announces QIP Launch | RITES Receives Major Overseas Project | Top Buzzing Stocks TodayEquitymaster
Blue Jet Healthcare Announces QIP Launch | RITES Receives Major Overseas Project | Top Buzzing Stocks Today - Equitymaster
Blue Jet Healthcare Announces QIP Launch | RITES Receives Major Overseas Project | Top Buzzing Stocks TodayEquitymaster
Medical device maker Zimmer Biomet to hire 500 employees in 3 years for tech centre in India
Medical device giant Zimmer Biomet is set to significantly expand its Indian footprint by hiring 500 professionals over three years for its new Bengaluru technology hub. Focusing on AI, software engineering, and R&D, the company aims to drive innovation in orthopedic implants and surgical devices. This move underscores India's growing importance as a global capability center for healthcare firms.
Healthcare, banks and EVs remain long-term bets: Invesco Mutual Fund's Taher Badshah
Taher Badshah, Chief Investment Officer at Invesco Mutual Fund, expects EV adoption to increase gradually with policy support, while opportunities are emerging in power distribution alongside transmission. Badshah also said SIP inflows remain stable and mutual fund industry trends are not showing signs of concern.
Stock Alert: Aurobindo Pharma, Likhitha Infra, Vikran Engineering, Ashoka Buildcon, Bajaj Healthcare
Aurobindo Pharma announced that the United States Food and Drug Administration (USFDA) had completed an inspection at its wholly owned subsidiary, Auroactive Pharma, located in Andhra Pradesh.
Stocks to Watch for June 29: HDFC Bank, Kotak Mahindra Bank, Dr Reddy’s and more
After an extended weekend, Dalal Street returns to a packed corporate news flow. From IRFC's successful OFS and Power Grid's fundraising plans to fresh developments at HDFC Bank, KEC International, Aurobindo Pharma and Bajaj Healthcare, here are the stocks likely to remain in focus on Monday.
Buy, Sell Or Hold: Suzlon, PVR Inox, IRFC, NCC And Fortis Healthcare — Ask Profit
Market experts shared buy, sell and hold recommendations for an array of stocks.
Hyderabad-based Pulsus to invest Rs 500 crore in Telangana AI healthcare hub, targets 6,000 jobs
Pulsus Group will invest Rs 500 crore to expand its AI healthcare and digital innovation hub in Telangana, creating 6,000 direct and 30,000 indirect jobs. This expansion, following a Supreme Court ruling upholding its SEZ status, will focus on AI-led healthcare solutions, digital services, and clinical research support.
Nifty 50 target cut by Citi to 26,000 - Key risk factors, top picks explained
Citi has highlighted Financials, Telecom, Healthcare, Defence and Utilities as their key "overweights", while IT Services, Staples, Metals are their top "underweights." It has also added Hitachi Energy into its list of top picks having initiated coverage on the stock recently.
Healthcare, engineering and specialty chemicals remain key market themes: Mayuresh Joshi
Mayuresh Joshi, Director Research at Marketsmith India, believes execution will remain key for companies like Suzlon, while healthcare, engineering and select speciality chemical names continue to offer strong growth opportunities. He also sees India-focused engineering and capital goods companies remaining resilient despite global uncertainties. Joshi says investors should stay selective in IT, remains positive on Navin Fluorine, and is closely tracking niche AI-linked opportunities emerging in smaller tech firms.